Cargando…

Impact of rosiglitazone meta-analysis on use of glucose-lowering medications

BACKGROUND: In May 2007 Nissen and Wolski reported the results of a meta-analysis showing an association between use of rosiglitazone and increased risk of myocardial infarction (N Engl J Med 2007;356(24):2457–2471). Rosiglitazone is an insulin-sensitizing agent used to control blood glucose levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morrow, Richard L, Carney, Greg, Wright, James M, Bassett, Ken, Sutherland, Jenny, Dormuth, Colin R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Medicine Publications, Inc. 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116669/ https://www.ncbi.nlm.nih.gov/pubmed/21686295

Ejemplares similares

Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2009)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2010)

Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study
por: Carney, Greg A, et al.
Publicado: (2012)

Policy‐induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia
por: Fisher, Anat, et al.
Publicado: (2019)

Comparison of cholinesterase inhibitor safety in real-world practice
por: Carney, Greg, et al.
Publicado: (2019)

Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis
por: Dormuth, Colin R, et al.
Publicado: (2008)

Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada
por: Carney, Greg, et al.
Publicado: (2022)

Outcomes associated with hospital admissions for accidental opioid overdose in British Columbia: a retrospective cohort study
por: Morrow, Richard L, et al.
Publicado: (2019)

A cluster randomized trial assessing the impact of personalized prescribing feedback on antibiotic prescribing for uncomplicated acute cystitis to family physicians
por: Carney, Greg, et al.
Publicado: (2023)

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
por: Colhoun, H. M., et al.
Publicado: (2012)

Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis
por: Fisher, Anat, et al.
Publicado: (2016)

Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis—A Meta-Analysis
por: Fisher, Anat, et al.
Publicado: (2017)

Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis – A Population-Based Cohort Study
por: Fisher, Anat, et al.
Publicado: (2014)

Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia
por: Fisher, Anat, et al.
Publicado: (2022)

Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohort
por: Fisher, Anat, et al.
Publicado: (2014)

Rosiglitazone RECORD study: glucose control outcomes at 18 months
por: Home, P D, et al.
Publicado: (2007)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Simpson's paradox visualized: The example of the Rosiglitazone meta-analysis
por: Rücker, Gerta, et al.
Publicado: (2008)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage
por: Cadarette, S. M., et al.
Publicado: (2011)

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
por: Galindo, Demi C., et al.
Publicado: (2020)

Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials
por: Monami, Matteo, et al.
Publicado: (2008)

Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial
por: Hanley, Anthony J., et al.
Publicado: (2010)

Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells
por: Lau, Meng-Fei, et al.
Publicado: (2018)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

Rosiglitazone promotes glucose metabolism of GIFT tilapia based on the PI3K/Akt signaling pathway
por: Guan, Dong‐Yan, et al.
Publicado: (2021)

Rosiglitazone enhances the apoptotic effect of 5-fluorouracil in colorectal cancer cells with high-glucose-induced glutathione
por: Lau, Meng-Fei, et al.
Publicado: (2019)

Activation of PPARγ by Rosiglitazone Does Not Negatively Impact Male Sex Steroid Hormones in Diabetic Rats
por: Mansour, Mahmoud, et al.
Publicado: (2009)

Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol
por: Holbrook, Anne, et al.
Publicado: (2016)

PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
por: Giacalone, Giovanna, et al.
Publicado: (2018)

Topical Rosiglitazone Is an Effective Anti-Scarring Agent in the Cornea
por: Huxlin, Krystel R., et al.
Publicado: (2013)

Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
Publicado: (2011)

Safety and efficacy of rosiglitazone in the elderly diabetic patient
por: Viljoen, Adie, et al.
Publicado: (2009)

The effect of Korean Red Ginseng extract on rosiglitazone-induced improvement of glucose regulation in diet-induced obese mice
por: Oh, Mi-Jeong, et al.
Publicado: (2017)

Public reporting of clinical trial findings as an ethical responsibility to participants: a qualitative study
por: Morrow, Richard L, et al.
Publicado: (2023)

Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits
por: Morrow, Richard L, et al.
Publicado: (2019)

Rosiglitazone Prevents High Glucose-Induced Vascular Endothelial Growth Factor and Collagen IV Expression in Cultured Mesangial Cells
por: Whiteside, Catharine, et al.
Publicado: (2009)

Beneficial Effects of Aerobic Exercise Training Combined with Rosiglitazone on Glucose Metabolism in Otsuka Long Evans Tokushima Fatty Rats
por: Piao, Shan-Ji, et al.
Publicado: (2017)

In vivo effects of rosiglitazone in a human neuroblastoma xenograft
por: Cellai, I, et al.
Publicado: (2010)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9rfq6tauooajv921j814iaop6d